Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 80 results for "lupin"

Aurobindo Pharma wrests second position among drug firms from Lupin
Business Standard

Aurobindo Pharma wrests second position among drug firms from ...

While Lupin recorded a 10.6 per cent decline in its sales for the period, the largest, Sun Pharma, recorded a 17.4 per cent fall Abhineet Kumar | Mumbai Last Updated at February 19, 2018 23:24 IST Aurobindo Pharma P V Ramaprasad Reddy, co-founder of Aurbindo ... Business Standard, 15 hours ago
Pharma shares gain; Sun Pharma hits seven-month high Business Standard, 1 month ago

96 images for lupin

Business Standard, 15 hours ago
Sify, 1 week ago
Business Standard, 1 week ago
Business Standard, 1 week ago
Money Control, 1 week ago
Business Standard, 1 week ago
Business Standard, 1 week ago
Business Standard, 1 week ago
Money Control, 1 week ago
Money Control, 1 week ago
Money Control

Lupin gains 3% on launch of generic Tamiflu capsules in US market

The company announced the launch of its Oseltamivir Phosphate Capsules, USP having received an approval from the United States Food and Drug Administration (FDA) earlier.
 Money Control1 week ago Lupin launches generic Tamiflu treatment capsules in US market  Business Standard1 week ago Lupin launches generic influenza treatment capsules in US  Money Control1 week ago Lupin launches generic Kapvay tablets in US  Money Control1 week ago
Sify

Lupin net plunges 65% in Q3

Mumbai: Pharma major Lupin Ltd on Tuesday reported a whopping 65 per cent annual decline in consolidated net profit to Rs 222 crore for the third quarter of 2017-18 from Rs 633 crore in the same period year ago. In a regulatory filing on the BSE, the ...
 Sify1 week ago Lupin Q3 net plunges 65% to Rs 2.2 bn on lower sales in North America  Business Standard2 weeks ago Lupin net profit drops 51.3% on sliding US biz and forex loss  Money Control2 weeks ago
Business Standard

Lupin, Dr Reddy's, Glenmark and Taro see up to 40% decline in the US sales

Requires you to share personal information like date of birth, income, location amongst other fields. This information alongwith your contact information will be shared with the partners associated with this program, who contribute towards subsidizing the ...
 Business Standard1 week ago
Business Standard

Market Update: Sigh of relief as Sensex, Nifty trade positive; HPCL top gainer, HDFC most active, Lupin at new 52-week low

The market breadth was in favour of the advances on Wednesday morning with 1472 stocks advancing while 169 stocks declined and 372 stocks remained unchanged. On the BSE, 2035 stocks advanced while 337 stocks declined and 66 remained unchanged.
 Money Control1 week ago Lupin hits 52-week low on weak Q3 results  Business Standard1 week ago Market Update: 91 stocks hit new 52-week high on NSE, LT, Tata Motors top gainers; Lupin hits 52-week low  Money Control2 months ago
Business Standard

Lupin-Yoshindo JV completes global phase III trials of its RA biosimilar

The randomised trial of 52 weeks was conducted in 11 countries and included over 500 patients, Lupin said Press Trust of India | Pune Last Updated at February 7, 2018 23:04 IST Drug major Lupin today said its joint venture with Japanese firm Yoshindo, YL ...
 Business Standard1 week ago Lupin steps up focus on biosimilars with an eye on $24 bn global market  Business Standard1 week ago

Lupin Ltd is up for a third straight session today

e stock is quoting at Rs 820.65, up 1.01% on the day as on 12:54 IST on the NSE. Lupin Ltd is down 44.02% in last one year as compared to a 18.96% jump in NIFTY and a 12.09% jump in the Nifty Pharma index. Lupin Ltd is up for a third straight session today.
 Business Standard1 week ago
Money Control

Pharma weekly wrap: Lupin, Glenmark post nos; Singh brothers resign from Fortis board

The highlights of the week include resignation Malvinder and Shivinder Singh promoters of Fortis from the Board and Q3 results of some major pharmaceutical companies.
 Money Control1 week ago
Money Control

Lupin hopes to resolve warning letter on Goa and Indore plants by end of FY19

Lupin was hit by a warning letter from USFDA for its manufacturing plants in Goa and Pithampur Unit II (Indore) in November last year.
 Money Control2 weeks ago

US Inflation Data; Key Earnings Report; Lupin & Bharti Airtel among Other Top Stocks to Sway Markets Today

Posted by Equitymaster On Thursday, Indian share markets ended higher on Monday, taking cues from its Asian peers. The S&P BSE Sensex ended at 34,300, up 294 points while the broader Nifty index settled at 10,539, up 84 points. Gains were largely seen in ...
 Equitymaster.com5 days ago Strong Start to the Week; HDFC Hits All Time High  Equitymaster.com1 month ago ECB, BoE Meetings; WPI Inflation; Gujarat Exit Poll & Top Cues to Move Markets Today  Equitymaster.com2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less